NO993066L - Ny behandling for leddinflammasjon - Google Patents

Ny behandling for leddinflammasjon

Info

Publication number
NO993066L
NO993066L NO993066A NO993066A NO993066L NO 993066 L NO993066 L NO 993066L NO 993066 A NO993066 A NO 993066A NO 993066 A NO993066 A NO 993066A NO 993066 L NO993066 L NO 993066L
Authority
NO
Norway
Prior art keywords
joint inflammation
new treatment
treatment
subtance
glucocorticoid
Prior art date
Application number
NO993066A
Other languages
English (en)
Norwegian (no)
Other versions
NO993066D0 (no
Inventor
Roger Hollgren
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO993066D0 publication Critical patent/NO993066D0/no
Publication of NO993066L publication Critical patent/NO993066L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO993066A 1996-12-20 1999-06-21 Ny behandling for leddinflammasjon NO993066L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9604751A SE9604751D0 (sv) 1996-12-20 1996-12-20 New therapy
PCT/SE1997/002124 WO1998027987A1 (en) 1996-12-20 1997-12-16 New treatment for joint inflammation

Publications (2)

Publication Number Publication Date
NO993066D0 NO993066D0 (no) 1999-06-21
NO993066L true NO993066L (no) 1999-06-21

Family

ID=20405107

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993066A NO993066L (no) 1996-12-20 1999-06-21 Ny behandling for leddinflammasjon

Country Status (20)

Country Link
US (1) US6432937B1 (hu)
EP (1) EP0957922A1 (hu)
JP (1) JP2001507024A (hu)
KR (1) KR20000069594A (hu)
AU (1) AU5502598A (hu)
BR (1) BR9713975A (hu)
CA (1) CA2274769A1 (hu)
CZ (1) CZ219399A3 (hu)
EE (1) EE9900258A (hu)
HU (1) HUP0000397A3 (hu)
ID (1) ID21763A (hu)
IL (1) IL130485A0 (hu)
IS (1) IS5056A (hu)
NO (1) NO993066L (hu)
NZ (1) NZ336025A (hu)
PL (1) PL334012A1 (hu)
SE (1) SE9604751D0 (hu)
SK (1) SK82699A3 (hu)
TR (1) TR199901413T2 (hu)
WO (1) WO1998027987A1 (hu)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010510227A (ja) 2006-11-20 2010-04-02 プレジデント アンド フェロウズ オブ ハーバード カレッジ 痛みおよび痒みの治療方法、組成物およびキット
WO2010071865A1 (en) 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
US20100160351A1 (en) * 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
EP3485881B1 (en) 2009-07-10 2024-03-13 President and Fellows of Harvard College Permanently charged sodium and calcium channel blockers as anti-inflammatory agents
WO2011032175A1 (en) 2009-09-14 2011-03-17 Nuon Therapeutics, Inc. Combination formulations of tranilast and allopurinol and methods related thereto
UA112769C2 (uk) 2011-02-18 2016-10-25 Ендо Фармасьютікалз Інк. Аміноінданові сполуки і їх застосування при лікуванні болю
CA2853279C (en) 2011-10-24 2021-03-23 Endo Pharmaceuticals Inc. Cyclohexylamines
BR112016013734A2 (pt) 2013-12-16 2017-08-08 Asana Biosciences Llc Composto, composição farmacêutica, kit, e uso de um composto
MX2018001447A (es) 2015-08-03 2019-02-21 Harvard College Bloqueadores de canal de ion cargado y metodos para su uso.
JP2016193937A (ja) * 2016-08-09 2016-11-17 株式会社エヌ・エル・エー 関節痛緩和組成物および機能性食品、並びに発酵ショウガ及びその製造方法
RU2019112740A (ru) 2016-09-30 2020-11-02 АСАНА БАЙОСАЙЕНСИЗ, ЭлЭлСи P2x3 и/или p2x2/3 соединения и способы
WO2020185881A1 (en) 2019-03-11 2020-09-17 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
JP2022527438A (ja) 2019-03-11 2022-06-02 ノシオン セラピューティクス,インコーポレイテッド 荷電したイオンチャンネル遮断薬および使用方法
US10927096B2 (en) 2019-03-11 2021-02-23 Nocion Therapeutics, Inc. Ester substituted ion channel blockers and methods for use
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10786485B1 (en) 2019-03-11 2020-09-29 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
JP2023500891A (ja) 2019-11-06 2023-01-11 ノシオン セラピューティクス,インコーポレイテッド 荷電したイオンチャンネル遮断薬および使用方法
WO2021091586A1 (en) 2019-11-06 2021-05-14 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US11332446B2 (en) 2020-03-11 2022-05-17 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8903914D0 (sv) 1989-11-22 1989-11-22 Draco Ab Oral composition for the treatment of inflammatory bowel diseases
GR1001529B (el) * 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
CA2140660A1 (en) * 1993-06-13 1994-12-22 Uwe R. Juergens Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system

Also Published As

Publication number Publication date
CZ219399A3 (cs) 1999-09-15
HUP0000397A3 (en) 2001-01-29
ID21763A (id) 1999-07-22
AU5502598A (en) 1998-07-17
SE9604751D0 (sv) 1996-12-20
HUP0000397A2 (hu) 2000-10-28
NZ336025A (en) 2001-02-23
PL334012A1 (en) 2000-01-31
NO993066D0 (no) 1999-06-21
IL130485A0 (en) 2000-06-01
CA2274769A1 (en) 1998-07-02
SK82699A3 (en) 2000-02-14
EE9900258A (et) 1999-12-15
TR199901413T2 (xx) 1999-08-23
BR9713975A (pt) 2000-04-11
JP2001507024A (ja) 2001-05-29
IS5056A (is) 1999-05-27
WO1998027987A1 (en) 1998-07-02
EP0957922A1 (en) 1999-11-24
US6432937B1 (en) 2002-08-13
KR20000069594A (ko) 2000-11-25

Similar Documents

Publication Publication Date Title
NO993066L (no) Ny behandling for leddinflammasjon
AU6675198A (en) Transdermal drug delivery system for the administration of tamsulosin, and related compositions and methods of use
AR021981A1 (es) Composicion farmaceutica para una administracion por via oral destinada a evitar la desviacion de uso en detrimento de un tercero
FI964249A (fi) Muovipäällysteinen, amoksisilliinia ja klavulanaattia käsittävä tabletti
CO4290346A1 (es) Formas de dosificacion de liberacion controlada de azitromicina
EE05506B1 (et) Ravimi manustamise vahend eriti progestiinide ja”strogeenide manustamiseks
DE69710065D1 (de) Androsten-derivate
ID23806A (id) Komposisi-komposisi farmasi untuk pemberian oral yang terdiri dari bahan aktif dan siklodekstrin
EE9600172A (et) Puriin-6-ooni derivaadid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja ravimid
HUP9903931A2 (hu) Indolopirrolokarbazolok citotoxikus aminocukor- és más rokon jellegű cukorszármazékai
NO20004419L (no) Ny anvendelse
DE69932510D1 (de) Vaskularisierungsinhibitoren
DK1033990T3 (da) 21-Hydroxy-6,19-oxidoprogesteron (21OH-6OP) dets anvendelse som medikament i behandling af glucocorticoidoverskud
RS49701B (sr) Vodene suspenzije za nazalnu primenu
ATE291914T1 (de) Zolmitriptanhaltige arzneizusammensetzungen
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
RS49599B (sr) Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija
EE04954B1 (et) Peroraalselt v?i paikselt manustatav farmatseutiline preparaat ja selle ravimvorm
TR200002248T2 (tr) Yeni dihidroksiheksanoik asit türevleri
DK1189595T3 (da) Ophthalmiske sammensætninger i form af vandige geler
NO20001717D0 (no) Serotonin-inneholdende formulering for oral administrering og anvendelse av samme
ATE28188T1 (de) Antikonvulsive mittel.
ES2131482A1 (es) Formulacion acuosa de bambuterol.
DK0927031T3 (da) Farmaceutisk sammensætning indeholdende nimesulid til oral admnistration
ATE57526T1 (de) P-acylaminobenzamide.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application